Cimetidine 200mg tablets

Šalis: Didžioji Britanija

kalba: anglų

Šaltinis: MHRA (Medicines & Healthcare Products Regulatory Agency)

Veiklioji medžiaga:

Cimetidine

Prieinama:

Tillomed Laboratories Ltd

ATC kodas:

A02BA01

INN (Tarptautinis Pavadinimas):

Cimetidine

Dozė:

200mg

Vaisto forma:

Oral tablet

Vartojimo būdas:

Oral

Klasė:

No Controlled Drug Status

Recepto tipas:

Valid as a prescribable product

Produkto santrauka:

BNF: 01030100; GTIN: 5024655000913

Pakuotės lapelis

CIMETIDINE 200MG, 400MG AND 800MG TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU
•
Keep this leaflet. You may need to read it again
•
If you have any further questions, ask your doctor, pharmacist or
nurse
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may
harm them, even if their signs of illness are the same as yours
If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible
side effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET:
1. What Cimetidine is and what it is used for
2. What you need to know before you take Cimetidine
3. How to take Cimetidine
4. Possible side effects
5. How to store Cimetidine
6. Contents of the pack and other information
1. WHAT CIMETIDINE IS AND WHAT IT IS USED FOR
The name of your medicine is Cimetidine 200mg Tablets Cimetidine 400mg
Tablets or Cimetidine
800mg Tablets (all called Cimetidine in this leaflet). Cimetidine
belongs to a group of medicines called
“H2 antagonists”.
Cimetidine works by lowering the amount of acid in your stomach. It
can be used for the following:
•
To treat or prevent ulcers in your stomach and duodenum (the part of
the gut the
stomach empties into)
•
An inflamed food pipe (oesophagitis) where stomach acid has travelled
up into your food
pipe (acid reflux disease)
•
To prevent ulcers from bleeding in seriously ill people
•
The management of Zollinger-Ellison Syndrome. This is a problem with
your pancreas where
too much acid in the stomach can cause ulcers in your stomach,
duodenum, gut and food
pipe
•
The management of short bowel syndrome. This is where some parts of
your bowel either do
not work or have been removed
•
If your pancreas does not work and you are taking enzyme supplements
to help you digest
your food
•
For people at risk of breathing in acid from their stomach
(aspiration). This might happen
during an operation with a general anaesthetic

Prekės savybės

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Cimetidine 200 mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 200 mg cimetidine.
For the full list of excipients, see section 6.1
3
PHARMACEUTICAL FORM
Film-coated tablet.
A pale green, round, convex, film-coated tablet with an approximate
diameter
of 9.5mm, coded CIM/200 on one side with score-line on the other
The score line is not intended for breaking the tablet
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Cimetidine is a histamine H
2
-receptor antagonist which rapidly inhibits both
basal and stimulated gastric secretion of acid and reduces pepsin
output.
Cimetidine
is
indicated
in
the
treatment
of
duodenal
or
benign
gastric
ulceration,
including
that
associated
with
non-steroidal
anti-inflammatory
agents,
recurrent
and
stomal
ulceration.
Reflux
eosophagitis
and
other
conditions where reduction of gastric acid by Cimetidine has been
shown to be
beneficial:
persistent
dyspeptic
symptoms
with
or
without
ulceration,
particularly meal-related upper abdominal pain, including such
symptoms
associated
with
non-steroidal
anti-inflammatory
agents.
Zollinger-Ellison
syndrome. Prophylaxis of stress ulceration in seriously acutely ill
patients.
Prophylaxis of acid aspiration syndrome and before general anaesthesia
in
patients thought to be at risk of acid aspiration (Mendelson's
Syndrome),
particularly obstetric patients during labour; to reduce malabsorption
and fluid
loss in the short bowel syndrome; and in pancreatic insufficiency to
reduce
degradation of enzyme supplements.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
POSOLOGY
The total daily dose by any route should not normally exceed 2.4g.
Dosage
should be reduced in patients with impaired renal function (see
Special
warnings and precautions for use)
_ADULTS _
For patients with duodenal or benign gastric ulceration, a single
daily dose of
800 mg at bedtime is recommended. Otherwise the usual dosage is 400 mg
twice a day with breakfast and at bedtime. Other effective